menu search

BOLT / Bolt Biotherapeutics: A Promised Follow Up

Bolt Biotherapeutics: A Promised Follow Up
Today, we post a promised follow-up on early stage biotech concern Bolt Biotherapeutics. The company has suffered some setbacks over the past year, but the stock now trades for approximately one-third of the cash on its balance sheet. Read More
Posted: Aug 26 2022, 15:24
Author Name: Seeking Alpha
Views: 092177

BOLT News  

Bolt Biotherapeutics to Participate in September Investor Conferences

By GlobeNewsWire
September 5, 2023

Bolt Biotherapeutics to Participate in September Investor Conferences

REDWOOD CITY, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing no more_horizontal

Bolt Biotherapeutics to Present at BTIG Virtual Biotechnology Conference 2023

By GlobeNewsWire
July 31, 2023

Bolt Biotherapeutics to Present at BTIG Virtual Biotechnology Conference 2023

REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing nov more_horizontal

Bolt Biotherapeutics: A Promised Follow Up

By Seeking Alpha
August 26, 2022

Bolt Biotherapeutics: A Promised Follow Up

Today, we post a promised follow-up on early stage biotech concern Bolt Biotherapeutics. The company has suffered some setbacks over the past year, bu more_horizontal

Bolt, Orion-E to build solar plants in Brazil for about $630 million

By Reuters
August 23, 2022

Bolt, Orion-E to build solar plants in Brazil for about $630 million

Energy infrastructure company Orion-E has reached an agreement with energy trader Bolt to build solar photovoltaic plants in Brazil with a combined ca more_horizontal


Search within

Pages Search Results: